Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors
Clinical trial NCT03317743 · COMPLETED
Trial details
- NCT number
- NCT03317743
- Sponsor
- Idience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-29
- Primary completion
- 2020-12-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.